TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
INKT

Mink Therapeutics Inc

Healthcare · Biotechnology

9.50$ -6.8% vs. previous close Closing price · As of: Nov 12, 2026

Ownership

Ownership Structure

Who owns Mink Therapeutics Inc (INKT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 40.4% of the shares are freely tradable; institutional investors hold 3.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 3.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 60.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 40.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 5Mio.

Largest Shareholders

Institutions

Institutions INKT
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 1.35 68,660 +15.7 06/30/2026
DnB NOR Asset Management (Asia) 1.08 55,142 +0.0 06/30/2026
Longbow Finance SA 0.33 16,667 +0.0 06/30/2026
Geode Capital Management, LLC 0.31 15,573 -10.2 06/30/2026
Citadel Advisors Llc 0.30 15,440 +0.0 06/30/2026
BlackRock Inc 0.26 13,382 +115.7 06/30/2026
Vanguard Fiduciary Trust Co 0.16 8,287 +0.0 06/30/2026

Funds

Funds INKT
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.04 53,070 +0.0 09/30/2026
DNB Fund Disrpt Opps A EUR Acc 0.97 49,521 -10.2 09/30/2026
Fidelity Extended Market Index 0.13 6,753 -0.5 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings INKT
Person Role Shares Value As of Type
Buell Jennifer Chief Executive Officer 74,195 704,853 $ Oct 12, 2026 direct
Corvese Brian Director 54,770 520,315 $ Sep 1, 2026 direct
Behner Peter Director 24,404 231,838 $ Sep 1, 2026 direct
Wiinberg Ulf Director 23,929 227,326 $ Sep 1, 2026 direct
Ryan Barbara Director 23,591 224,115 $ Sep 1, 2026 direct
Holcomb John Bradley Director 4,691 44,565 $ Sep 1, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 12, 2026 Buell Jennifer Chief Executive Officer Sell 6,938 10.56 73,265
Oct 11, 2026 Buell Jennifer Chief Executive Officer Other 23,191 – –
Sep 1, 2026 Wiinberg Ulf Director Other 1,279 10.95 14,005
Sep 1, 2026 Holcomb John Bradley Director Other 1,233 10.95 13,501
Sep 1, 2026 Behner Peter Director Other 1,485 10.95 16,261
Sep 1, 2026 Ryan Barbara Director Other 1,622 10.95 17,761
Sep 1, 2026 Corvese Brian Director Other 1,633 10.95 17,881

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?